Katherine C. Dodd

Salford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Periprocedural antithrombotic management for lumbar puncture: Association of British Neurologists 2026 guideline summary update.

Periprocedural antithrombotic management for lumbar puncture: Association of British Neurologists 2026 guideline summary update.

Journal: Practical neurology

Published: August 03, 2026

Inclusive approaches to research and healthcare for nitrous oxide users: lessons from a longitudinal study.

Inclusive approaches to research and healthcare for nitrous oxide users: lessons from a longitudinal study.

Journal: BMJ neurology open

Published: December 22, 2025

Beyond access: Uncovering hidden public health benefits of participating in experimental medicine trials through detection of clinically significant findings at screening.

Beyond access: Uncovering hidden public health benefits of participating in experimental medicine trials through detection of clinically significant findings at screening.

Journal: Public health

Published: November 18, 2025

Frequent co-occurrence of AChR-positive myasthenia gravis in facioscapulohumeral muscular dystrophy suggests a novel disease association.

Frequent co-occurrence of AChR-positive myasthenia gravis in facioscapulohumeral muscular dystrophy suggests a novel disease association.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: September 03, 2025

FcRn inhibitors for myasthenia gravis.

FcRn inhibitors for myasthenia gravis.

Journal: The Cochrane database of systematic reviews

Published: August 22, 2025

Complement inhibitors for myasthenia gravis in adults.

Complement inhibitors for myasthenia gravis in adults.

Journal: The Cochrane database of systematic reviews

Published: July 08, 2025

Rituximab for myasthenia gravis.

Rituximab for myasthenia gravis.

Journal: The Cochrane database of systematic reviews

Published: July 03, 2025

Lymphocyte alterations and elevated complement signaling are key features of refractory myasthenia gravis.

Lymphocyte alterations and elevated complement signaling are key features of refractory myasthenia gravis.

Journal: Med (New York, N.Y.)

Published: April 23, 2025

Utilising accessible and reproducible neurological assessments in clinical studies: Insights from use of the Neurological Impairment Scale in the multi-centre COVID-CNS study.

Utilising accessible and reproducible neurological assessments in clinical studies: Insights from use of the Neurological Impairment Scale in the multi-centre COVID-CNS study.

Journal: Clinical medicine (London, England)

Published: July 30, 2024

Addressing ethnic disparities in neurological research in the United Kingdom: An example from the prospective multicentre COVID-19 Clinical Neuroscience Study.

Addressing ethnic disparities in neurological research in the United Kingdom: An example from the prospective multicentre COVID-19 Clinical Neuroscience Study.

Journal: Clinical medicine (London, England)

Published: March 15, 2024

Mycophenolate and methotrexate are better tolerated than azathioprine in myasthenia gravis.

Mycophenolate and methotrexate are better tolerated than azathioprine in myasthenia gravis.

Journal: Neuromuscular disorders : NMD

Published: December 19, 2023

Patients with neurological or psychiatric complications of COVID-19 have worse long-term functional outcomes: COVID-CNS-A multicentre case-control study.

Patients with neurological or psychiatric complications of COVID-19 have worse long-term functional outcomes: COVID-CNS-A multicentre case-control study.

Journal: Scientific reports

Published: December 11, 2023

Showing 1-12 of 24

Last Updated: 09/26/2026